Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.
A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...
The CDC provides a free online video for healthcare providers on testing for Clostridium difficile. In the video, Dr. Carolyn Gould, a medical epidemiologist in the Division of Healthcare Quality ...
Tests for the Clostridium difficile infection are missing up to 20% of cases and falsely diagnosing thousands of others, researchers have said. A study by St George's, University of London, and St ...
Funded by a $230,979 grant, an Ohio University study tests metformin to prevent Clostridioides difficile in heart patients.
For the study, researchers at the Fargo (N.D.) VA Healthcare System allowed hospital nurses to independently order stool samples for patients displaying C. diff symptoms without requiring a ...
Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...
Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...
Great Basin Corporation Submits 510(K) Application to FDA for C. Difficile Molecular Diagnostic Test
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results